Impact of Routine Quantiferon Testing on Latent Tuberculosis Diagnosis and Treatment in Refugees in Multnomah County, Oregon, November 2009–October 2012
- 18 March 2015
- journal article
- Published by Springer Nature in Journal of Immigrant and Minority Health
- Vol. 18 (2) , 292-300
Abstract
Interferon-gamma release assays have potentially been transformative to screening programs focused on latent tuberculosis infection (LTBI) in foreign-born persons. We sought to add to this assessment by presenting the impact of a well-established refugee screening and treatment program switching from skin testing to Quantiferon®-TB Gold (QFT). We completed a retrospective cohort of refugees screened for tuberculosis between November 1, 2009–April 30, 2011 (pre-QFT) and May 1, 2011–October 31, 2012 (post-QFT). Among 2244 refugees screened that met the inclusion criteria, there was a significant difference in the proportion of refugees diagnosed with LTBI between the two time periods (p = p = 0.040). However, test type had no impact on treatment completion (odds ratio 0.88; 95 % CI 0.57–1.36, p = 0.560). Although we demonstrated increased efficiency in LTBI diagnosis in this group, treatment completion rates indicate other barriers to treatment that must be addressed.Keywords
This publication has 26 references indexed in Scilit:
- Trends in Tuberculosis — United States, 20132014
- Understanding of latent tuberculosis, its treatment and treatment side effects in immigrant and refugee patientsBMC Research Notes, 2013
- Faculty Opinions recommendation of Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection.2012
- Estimating the Burden of Tuberculosis among Foreign-Born Persons Acquired Prior to Entering the U.S., 2005–2009PLOS ONE, 2011
- Assessment and management of latent tuberculosis infection in a refugee population in the Northern TerritoryMedical Journal of Australia, 2011
- Latent Tuberculosis Infection in the United StatesNew England Journal of Medicine, 2011
- Improved Adherence and Less Toxicity With Rifampin vs Isoniazid for Treatment of Latent TuberculosisArchives of internal medicine (1960), 2006
- Determining TB rates and TB case burden for refugees.2005
- Acceptance of screening and completion of treatment for latent tuberculosis infection among refugee claimants in Canada.2004
- Changes in the Transmission of Tuberculosis in New York City from 1990 to 1999New England Journal of Medicine, 2002